By Allison Kubo Hutchison New research published May 10 in Nature Medicine adds to the stack of evidence that Psychedelic drugs can be used to treat mental health. The study administered their test group with 3,4-methylenedioxy-methamphetamine (MDMA) in an attempt to treat Post-Traumatic Stress Disorder (PTSD). After three eight-hour sessions supervised by an attentive therapist, it was “found to induce significant and robust attenuation” of suicidality and impairment. At the conclusion of the study, 67 percent of the participants who were given MDMA no longer qualified to be diagnosed with PTSD. However, it is unclear how long the effects will last and larger, more racially diverse studies are still necessary to establish robustness. This is just the latest data point in research on psychedelic treatment. Other studies have shown that psilocybin (an active component of magic mushrooms) or lysergic acid (LSD) lowers distress in cancer patients with end-of-life anxiety. Other
brought to you by the American Physical Society
